Active surveillance for favorable-risk prostate cancer: who, how and why?

被引：0
|
作者：
Laurence Klotz
机构：
[1] L Klotz is Chief of Urology at the Sunnybrook Health Sciences Centre,
[2] and Professor of Surgery at the University of Toronto,undefined
[3] Toronto,undefined
[4] ON,undefined
[5] Canada.,undefined
来源：
Nature Clinical Practice Oncology | 2007年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Active surveillance for favorable-risk prostate cancer has become increasingly popular in populations in which prostate cancer screening is widespread because of evidence that screening results in the detection of disease that is not clinically significant in many patients. This Review discusses the results of active surveillance, the criteria for patient selection and the appropriate thresholds for intervention.
引用
收藏
页码：692 / 698
页数：6
相关论文
共 50 条
  • [21] Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery
    Tosoian, Jeffrey J.
    Sundi, Debasish
    Trock, Bruce J.
    Landis, Patricia
    Epstein, Jonathan I.
    Schaeffer, Edward M.
    Carter, H. Ballentine
    Mamawala, Mufaddal
    EUROPEAN UROLOGY, 2016, 69 (04) : 576 - 581
  • [22] Active Surveillance for Favorable Risk Prostate Cancer PRO
    Klotz, Laurence
    JOURNAL OF UROLOGY, 2009, 182 (06): : 2565 - 2566
  • [23] Risk of missing advanced stage or high grade tumors during active surveillance (AS) even in favorable-risk prostate cancer (PC)
    Kim, Jeri
    Ward, John Francis
    Pettaway, Curtis A.
    Wang, Xuemei
    Kuban, Deborah A.
    Frank, Steven J.
    Lee, Andrew
    Pisters, Louis L.
    Matin, Surena F.
    Shah, Jay Bakul
    Karam, Jose A.
    Chapin, Brian Francis
    Papadopoulos, John N.
    Achim, Mary F.
    Hoffman, Karen Elizabeth
    Pugh, Thomas J.
    Choi, Seungtaek
    Logothetis, Christopher
    Troncoso, Patricia
    Davis, John W.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [24] Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer
    Tosoian, Jeffrey J.
    Mamawala, Mufaddal
    Epstein, Jonathan I.
    Landis, Patricia
    Wolf, Sacha
    Trock, Bruce J.
    Carter, H. Ballentine
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (30) : 3379 - +
  • [25] Re: Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery
    van den Bergh, Roderick C. N.
    Zargar, Homayoun
    Murphy, Declan G.
    EUROPEAN UROLOGY, 2016, 69 (05) : 964 - 965
  • [26] Active Surveillance for Favorable Risk Prostate Cancer BEWARE THE RISKS
    Parekh, Dipen J.
    JOURNAL OF UROLOGY, 2009, 182 (06): : 2566 - 2568
  • [27] Contemporary approach to active surveillance for favorable risk prostate cancer
    Klotz, Laurence
    ASIAN JOURNAL OF UROLOGY, 2019, 6 (02) : 146 - 152
  • [28] RISK PREDICTION TOOL FOR GRADE RECLASSIFICATION IN FAVORABLE-RISK MEN ON ACTIVE SURVEILLANCE
    Mamawala, Mufaddal
    Rao, Karthik
    Landis, Patricia
    Epstein, Jonathan
    Trock, Bruce
    Tosoian, Jeffrey
    Pienta, Kenneth
    Carter, H. Ballentine
    JOURNAL OF UROLOGY, 2016, 195 (04): : E230 - E230
  • [29] Re: Association between Early Confirmatory Testing and the Adoption of Active Surveillance for Men with Favorable-Risk Prostate Cancer Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2018, 200 (06): : 1164 - 1165
  • [30] IS FAVORABLE INTERMEDIATE RISK PROSTATE CANCER REALLY FAVORABLE? IMPLICATIONS FOR ACTIVE SURVEILLANCE STRATEGIES
    Haywood, Samuel
    Nyame, Yaw
    Liang, Helen
    Klein, Eric
    Stephenson, Andrew
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1055 - E1055
12345